Screening for type 2 diabetes to prevent vascular complications: updated recommendations from the Canadian Task Force on Preventive Health Care
Feig D S, Palda V A, Lipscombe L L, with the Canadian Task Force on Preventive Health Care
Record ID 32005001173
English
Authors' objectives:
This review updates the 1994 recommendations of the Canadian Task Force on Preventive Health Care for type 2 diabetes mellitus.
Authors' recommendations:
Recommendations
1. There is fair evidence to recommend screening adults with hypertension for type 2 diabetes to reduce the incidence of cardiovascular (CV) events and mortality (Grade B recommendation). 2. There is fair evidence to recommend screening adults with hyperlipidemia for type 2 diabetes to reduce the incidence of CV events and mortality (Grade B recommendation). 3. There is good evidence to recommend treatment of overweight individuals with impaired glucose tolerance (IGT) with lifestyle interventions to reduce the incidence of diabetes progression (Grade B recommendation). 4. There is insufficient evidence to recommend treatment of overweight individuals with IGT with metformin or acarbose to reduce the incidence of diabetes progression (Grade I 10 recommendation). 5. There is fair evidence to recommend treatment of overweight individuals with IGT with acarbose to prevent cardiovascular outcomes and hypertension (Grade B recommendation).
Authors' methods:
Systematic review
Details
Project Status:
Completed
URL for project:
http://www.ctfphc.org/Full_Text/CTF_DM_TR_final_2005.pdf
Year Published:
2003
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Diabetes Mellitus, Type 2
- Mass Screening
- Diabetic Angiopathies
- Vascular Diseases
Contact
Organisation Name:
Canadian Task Force on Preventive Health Care
Contact Address:
Canadian Task Force on Preventive Health Care, 100 Collip Circle, Suite 117, London, ON, N6G 4X8, Canada. Tel: 519-858-5181; Fax: 519-858-5112
Contact Name:
ctf@ctfphc.org
Contact Email:
ctf@ctfphc.org
Copyright:
Canadian Task Force on Preventive Health Care (CTFPHC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.